Community Outreach
» Community Health Program
» Flu & Pneumonia Clinics
» Immunizations
» Travel Immunizations
» Zoster Immunizations
» Speakers Bureau
Information
» Volunteer Opportunities
» Employment Opportunities
» Community & Healthcare Links
» 2007 Annual Report
» VNA Advantage Newsletter
Development
» Give a Gift
» Help Support our Cause
» Special Events
» United Way
Who are we?
» Company Profile
» Management Team
Contact Us
» Directions
» Contact Us

Home Health Care Management, Inc.
1170 Berkshire Boulevard
Wyomissing, PA 19610

Phone:
610.378.0481
800.346.7848

Fax:
610.378.9762
Advantage Home Care Link Berks Visiting Nurse Association Link Greater Lehigh Valley Visiting Nurse Association Link Visiting Nurse Association of Pottstown and Vicinity Link
Zoster Immunizations
Our Community Health Program is proud to introduce our Zoster Immunization Program.

Our program offers zoster live immunization (Zostavax®) to individuals 60 years of age or older for the prevention of shingles.  We offer convenient scheduling at our Wyomissing location by appointment only.

For additional information on Zoster Immunization (or any of our other Community Health Programs) or to schedule an appointment, please contact:

Information on Shingles

Shingles is caused by the Varicella Zoster virus, the same virus that causes chickenpox. Only someone who has had a case of chickenpox-or gotten chickenpox vaccine-can get shingles. The virus stays in your body. It can reappear many years later to cause a case of shingles.

Shingles is a painful skin rash, often with blisters. It is also called Herpes Zoster. A shingles rash usually appears on one side of the face or body and lasts from 2 to 4 weeks. Its main symptom is pain, which can be quite severe. Other symptoms can include fever, headache, chills, and upset stomach. Very rarely, a shingles infection can lead to pneumonia, hearing problems, blindness, brain inflammation or death. For about 1 in 5 persons, severe pain can continue even after the rash clears up. This is called post-herpetic neuralgia.

Shingles is far more common in people 50 and older than in younger people. It is also more common in people whose immune systems are weakened because of a disease such as cancer, or drugs such as steroids or chemotherapy. At least 1 million people a year in the United States get shingles.

Zostavax® vaccine manufactured by Merck was licensed in 2006. In clinical trials, the vaccine prevented shingles in about half of people 60 years of age and older. It can also reduce the pain associated with shingles.

Information sourced from CDC Shingles Vaccine Information Sheet (VIS/Interim) dated 9/11/06.


Copyright © 2007 Home Health Care Management, Inc. All Rights Reserved.